SQZ Biotechnologies - Stock Price History | SQZ

Historical daily share price chart and data for SQZ Biotechnologies since 2022 adjusted for splits. The latest closing stock price for SQZ Biotechnologies as of December 02, 2022 is 1.55.
  • The all-time high SQZ Biotechnologies stock closing price was 34.58 on December 28, 2020.
  • The SQZ Biotechnologies 52-week high stock price is 12.12, which is 681.9% above the current share price.
  • The SQZ Biotechnologies 52-week low stock price is 1.48, which is 4.5% below the current share price.
  • The average SQZ Biotechnologies stock price for the last 52 weeks is 4.45.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
SQZ Biotechnologies Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 14.7388 28.0000 29.9000 8.9300 8.9300 -69.19%
2020 25.5223 13.2500 34.5800 13.2500 28.9800 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.046B $0.027B
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $172.495B 10.52
GSK (GSK) United Kingdom $71.890B 9.01
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.433B 19.52
Ginkgo Bioworks Holdings (DNA) United States $3.861B 0.00
Myovant Sciences (MYOV) United Kingdom $2.605B 0.00
Arcus Biosciences (RCUS) United States $2.586B 38.81
Biohaven (BHVN) United States $1.141B 0.00
Emergent Biosolutions (EBS) United States $0.599B 4.71
Zymeworks (ZYME) Canada $0.478B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.278B 0.00
Enzo Biochem (ENZ) United States $0.096B 0.00
Gelesis Holdings (GLS) United States $0.035B 0.00
Ambrx Biopharma (AMAM) United States $0.019B 0.00